It was a busy Thursday in the big pharma world, with drugmaker Shire rejecting a $60 billion takeover offer from Japan’s Takeda, while US rival Allergan disclosed that it was considering a bid of its own for Shire – WSJ and Bloomberg and Law360

The Upshot on why global policymakers appear so concerned about a world economy that, by the numbers, at least, is humming along at its best clip in a decade – NYTimes and Bloomberg

A rise in the threat of global trade wars is part of the issue, and Japan’s booming auto exports could mean another front for the US’s newly protectionist bent – WSJ

The SEC wants more info about major tech firms’ segments. Amazon and Google aren’t playing ball – MarketWatch

More “yikes” news for Deutsche Bank, which admitted that it “inadvertently sent $35 billion to an exchange as part of its daily dealings in derivatives.” Though DB caught the error, the “episode raises fresh questions about the bank’s risk and control processes” – Bloomberg

A derivative shareholder suit in Maryland federal court is accusing Under Armour CEO Kevin Plank and two of UA’s directors with leveraging the company for their personal gain – Law360

Barclays CEO Jes Staley is emerging from his “attempting to unmask a whistleblower” scandal virtually unscathed. The UK’s FCA has fined Staley and could claw back some or all of his 2016 bonus, but his job is firmly intact. Barclays’ board has already expressed “unanimous confidence” in him – Bloomberg and NYTimes

One might think that all of the talk in recent months of tariffs and closing the US’s trade gap would be square in the Export-Import Bank’s wheelhouse. One would be wrong (because that would wrongly assume that the Ex-Im Bank has a quorum that would enable it to act) – NYTimes

SDNY Magistrate Judge Sarah Netburn has ruled that plaintiffs BlackRock and Royal Park cannot toll the statute of limitations on absent class members’ claims while they “await the outcome of a Second Circuit petition to appeal” the denial of class cert in their case against HSBC for “allegedly botching its trustee responsibilities” on hundreds of RMBS trusts – Law360

We’ll give Streetwise the last word (for now) on the yield curve. Your takeaway? While an inverted yield curve might indicate economic concerns, “whether it works or not as a recession indicator is something [investors] don’t have to worry about for a while yet” – WSJ

Science agrees with Gloria.  Get on your feet – NYTimes

Have a great weekend.